Amylyx Pharmaceuticals Inc (AMLX)
SG&A Expense Growth
35.60%
Quarterly · Period ending:
AMLX SG&A Expense Growth
Latest reported35.60%period ending
Latest reported35.60%period ending
AMLX Quarterly SG&A Growth (QoQ) (0.00% → 35.60%)
Latest values, visible window
High-resolution chart · PNG
AMLX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 35.599% | |
| 5.0481% | |
| -4.8232% | |
| 3.4015% | |
| -0.2805% | |
| -8.2646% | |
| -4.1003% | |
| -17.6422% | |
| -62.5219% | |
| 10.5626% | |
| 7.2314% | |
| 12.2767% | |
| -1.3975% | |
| 7.7417% | |
| 36.4195% | |
| -0.18% | |
| 13.8292% | |
| 76.5967% | |
| 44.1643% | |
| 35.1528% | |
| 27.5483% | |
| 52.8124% | |
| 0% |